• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 26, 2022
Market Access

Moderna looks to subscriptions as future of vaccine business

The goal is to get countries to sign 10-year contracts for pre-specified volumes
Read More
BioCentury | Nov 13, 2021
Data Byte

CHMP opinions for November include KRAS inhibitor sotorasib

Two new COVID-19 mAbs among recommended
Read More
BioCentury | Dec 2, 2019
Company News

Innovent’s Tyvyt edges out PD-1s on China’s 2020 reimbursement list

Read More
BioCentury | Jun 27, 2019
Politics & Policy

June 26 P&P Quick Takes: FDA solicits comments on transparency programs; plus Louisiana’s HCV drug model and more

Read More
BioCentury | Apr 26, 2019
Company News

Express Scripts excludes Lilly's low cost insulin generic from preferred formulary

Read More
BioCentury | Mar 26, 2019
Company News

Louisiana picks Gilead's generics unit for HCV subscription model

Read More
BioCentury | Mar 5, 2019
Company News

Lilly offers cheaper insulin, pressuring competitors

Read More
BioCentury | Jan 25, 2019
Clinical News

Cocrystal reports SVR12 rate of 67% for CC-31244 regimen

Read More
BioCentury | Dec 7, 2018
Clinical News

China approves Descovy, Harvoni, Hemlibra

Read More
BioCentury | Dec 4, 2018
Company News

China approves Descovy, Harvoni, Hemlibra

Read More
Items per page:
1 - 10 of 48